Asset
RILONACEPT
Kiniksa Pharmaceuticals International plc Class A Ordinary Shares
Revenue
No revenue reported in loaded filings.
Clinical trials (2)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT03980522 | phase2 | completed | 2018-01-24 | 2019-05-17 | Kiniksa Pharmaceuticals (UK), Ltd. | A Pilot Study of KPL-914 in Recurrent Pericarditis |
| NCT03737110 | phase3 | completed | 2019-01-07 | 2020-05-29 | Kiniksa Pharmaceuticals (UK), Ltd. | Study to Assess the Efficacy and Safety of Rilonacept Treatment in Participants With Recurrent Pericarditis |
FDA applications (1)
| Application | Type | Applicant |
|---|---|---|
| BLA 125249 | BLA | Kiniksa Pharmaceuticals (UK), Ltd. |
Marketed products (1)
- ARCALYST